Several reports have shown that glabrol inhibits the cancer targets cytochrome P450 1B1 enzyme (Sharma et al., 2017) and isoprenylcysteine carboxyl methyltransferase (Buchanan et al., 2008). This evidence concerns the gene CYP1B1 and cancer.